Our data clearly indicate that ENPP1, especially when the Q121variant is operating, affects insulin signaling and glucose metabolism inskeletal muscle- and liver-cells and both function and survival of insulinsecreting beta-cells, thus representing a strong pathogenic factor predisposingto insulin resistance, defective insulin secretion and glucose metabolismabnormalities. The gene discussed is ENPP1; the disease is Insulin resistance.